Search clinical trials for: adoptive Cellular Immunotherapy

Total 7036 results

National Cancer Institute (NCI)

Completed

Chemotherapy, Irradiation, Cell Infusions, and Interleukin-2 to Treat Metastatic Melanoma

Metastatic Melanoma

United States
Rennes University Hospital
Innate Pharma

Terminated

Immunotherapy of Hepatocellular Carcinoma With Gamma Delta T Cells (ICAR)

Hepatocellular Carcinoma

France
Hadassah Medical Organization

Withdrawn

Immunotherapy of Cancer Using Donor Lymphocytes Labelled With In-vitro Bispecific Antibodies.

Metastatic Solid Tumors

Israel
Hadassah Medical Organization
The International Center for Cell Therapy & Cancer Immunotherapy (CTCI)

Withdrawn

Allogeneic Tumor Cell Vaccination in Patients With Solid Tumors

Metastatic Solid Tumors

Israel
Hadassah Medical Organization

Withdrawn

Adoptive Immunotherapy for CMV Disease

CMV Disease

Israel
Quantum Immunologics, Inc.
University of South Alabama

Unknown

Cellular Immunotherapy Study With Autologous Dendritic Cells Loaded With Oncofetal Antigen/iLRP in Patients With Metastatic Breast Cancer

Breast Cancer

United States
Dendreon

Completed

Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy

Prostate Cancer

United States, Canada
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

No longer available

Emergency Use of Adoptive Immunotherapy With CMV-Specific T Cells After Donor Bone Marrow Transplant of an Infant With Immunodeficiency Syndrome and CMV Infection

Infection | Precancerous/Nonmalignant Condition

United States
University of Bologna

Unknown

Adoptive Immunotherapy of High Risk Acute Myeloblastic Leukemia Patients Using Haploidentical Kir Ligand-mismatched Natural Killer Cells

Myeloblastic Leukemia

Italy
Danish Headache Center

Completed

Carbachols Headache-inducing Effect and Changes in Cerebral Blood Flow in Migraine Patients

Headache

Denmark
Cell Genesys

Terminated

Docetaxel in Combination With GVAX ® Immunotherapy Versus Docetaxel and Prednisone in Prostate Cancer Patients

Prostate Cancer

United States, France, United Kingdom, Italy, Germany, Netherlands, Canada, Poland, Sweden, Belgium
National Institute of Allergy and Infectious Diseases...

Completed

Safety and Effectiveness of Immunotherapy With Autologous HIV-Specific CD8 Cells in HIV Infected Adults

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Safety and Survival of Genetically Modified White Blood Cells in HIV-Infected Persons - A Study in Identical Twin Pairs

Acquired Immunodeficiency Syndrome | HIV Infection

United States
Cell Genesys

Completed

Dose Escalation and Efficacy Trial of GVAX® Prostate Cancer Vaccine

Prostate Cancer

United States
Hadassah Medical Organization

Unknown

Cell Therapy of Cancer With Allogeneic Blood Lymphocytes Activated With Recombinant Interleukin-2 (rIL-2) for Metastatic Solid Tumors

Tumors

Israel
Rennes University Hospital
Ministry of Health, France

Terminated

Efficacy of Activated Lymphocytes in Renal Cell Carcinoma.

Metastatic Renal Cell Carcinoma

France
University of Lausanne Hospitals
Fond'action contre le cancer; Barletta Foundation; NCCR (National Center of Competence...

Suspended

Adoptive Cell Transfer Combined With Peptide Vaccination in Transiently Immunosuppressed Melanoma Patients

Melanoma

Switzerland
Cell Genesys

Completed

Prime-Boost Dose Scheduling Trial for Human GM-CSF Gene Transduced Irradiated Prostate Allogeneic Cancer Cell Vaccines (Allogeneic Prostate GVAX®)

Prostate Cancer
Cell Genesys

Completed

Vaccination Priming and Vaccine Boosting Trial of Allogeneic Human GM-CSF Gene Transduced Irradiated Prostate Cancer Cell Vaccines (GVAX® Vaccine for Prostate Cancer)

Prostate Cancer
Cell Genesys

Completed

Prime-Boost Dose Scheduling Trial for Human GM-CSF Gene Transduced Irradiated Prostate Allogeneic Cancer Vaccine (Allogeneic Prostate GVAX®) in Patients With Hormone-Refractory Prostate Cancer

Prostate Cancer
National Institute of Allergy and Infectious Diseases...

Completed

A Pilot Study of Allogeneic Lymphocyte Transfer in HIV Infection

HIV Infections

United States
Princess Maxima Center for Pediatric Oncology
EUSA Pharma, Inc.

Not yet recruiting

Study Combining Dinutuximab Beta With Two Chemotherapy Regimens in Neuroblastoma (DBPilot)

Neuroblastoma

Netherlands
Changzhi People's Hospital Affiliated to Changzhi...

Recruiting

A Real-world Study of Camrelizumab Alone or in Combination With Apatinib/Chemotherapy for Advanced Gastric Cancer

Gastric Cancer | PD-1 Immunotherapy | RWS

China
Gilead Sciences
GOG Foundation; European Network of Gynaecological Oncological Trial Groups...

Not yet recruiting

Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01)

Endometrial Cancer
Second Affiliated Hospital of Guangzhou Medical...

Recruiting

Checkpoint Inhibitor Combinations Therapy as First Line for Inoperable Lung Cancer Via IT

Lung Cancer | Inoperable Disease

China
Merck Sharp & Dohme LLC

Not yet recruiting

A Study of Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Plus Enfortumab Vedotin (EV) With Pembrolizumab in Advanced Urothelial Carcinoma (MK-3475-04C/KEYMAKER-U04)

Metastatic Urothelial Carcinoma | Locally Advanced Urothelial Carcinoma
Washington University School of Medicine
Pfizer; National Comprehensive Cancer Network; Rapid Novor

Not yet recruiting

Measurable Residual Disease-Guided Post-Transplant Elranatamab Maintenance Using Peripheral Blood Clonotypic Mass Spectrometry

Multiple Myeloma

United States
University Medical Center Groningen
Dutch Cancer Society

Not yet recruiting

IMPT Dose Escalation for NSCLC (HyDose) (HyDose)

Carcinoma, Non-Small-Cell Lung

Netherlands
Shanghai Chest Hospital

Not yet recruiting

Efficacy and Safety of Combination Therapy of Sintilimab and Chemotherapy With Cryoablation in NSCLC

Non-Small-Cell Lung Cancer
Ruijin Hospital

Recruiting

Perioperative Treatment of Resectable Adenocarcinoma of Esophagogastric Junction by Immunotherapy (Adebrelimab) Combined With Chemotherapy (XELOX): a Prospective, Single-center, Feasibility Study (AEGIS)

Esophagogastric Junction Adenocarcinoma

China
Adicet Therapeutics

Not yet recruiting

A Phase 1/2 Trial of ADI-270 in ccRCC

Clear Cell Renal Cell Carcinoma
University of Missouri-Columbia
National Institutes of Health (NIH)

Not yet recruiting

Evaluation of the Ketogenic Diet to Improve Post Operative Cognitive Decline in Cardiac Surgery

Postoperative Cognitive Dysfunction

United States
Intra-Cellular Therapies, Inc.

Recruiting

Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder

Generalized Anxiety Disorder

United States
RenJi Hospital

Recruiting

Evaluate the Safety and Efficacy of BGT007H Cell Therapy in Patients With Relapsed/Refractory Pancreatic Cancer

Tumor Pancreas

China
Yunnan Cancer Hospital

Recruiting

The Efficacy of Watch and Wait Strategy or Surgery After Neoadjuvant Immunotherapy for Locally Advanced Colorectal Cancer With dMMR/MSI-H Guided by MRD Dynamic Monitoring: A Single-center, Open-label, Prospective, Phase II Clinical Trial. (WINDOW)

Clinical Complete Response Rate With Negative MRD

China
Second Affiliated Hospital of Guangzhou Medical...
Immuno (Guangzhou) Biomedicine S&T Ltd

Recruiting

Interventional Software for Multi-immunotherapy of Solid Tumors

Lung Cancer | Liver Cancer | Solid Tumor, Adult

China
Nordlandssykehuset HF
University Hospital of North Norway; University of Tromso; Helgelandssykehuset...

Recruiting

Safer Personalised Cancer Treatment Digital Follow-up (SPecT)

Patient Reported Outcome Measure

Norway
Peking University Cancer Hospital & Institute

Not yet recruiting

A Study of AK112 Monotherapy in Advanced/Metastatic Renal Cell Carcinoma

Renal Cell Carcinoma
Maria Sklodowska-Curie National Research Institute...

Recruiting

Preoperative Immunotherapy Combined With Stereotactic Radiation Therapy Boost in the Treatment of HER2-negative Breast Cancer (BREAST-BOOSTER)

Breast Cancer

Poland
University of Illinois at Chicago

Not yet recruiting

TEXT4HF: Randomized Controlled Trial of a Tailored Text Messaging for Heart Failure (TEXT4HF)

Heart Failure
Zhiyong Huang
Hubei Cancer Hospital; Wuhan Union Hospital, China; Renmin Hospital of Wuhan... and other collaborators

Recruiting

Palliative Hepatectomy Combined With Targeted Therapy and Immunotherapy for Advanced Hepatocellular Carcinoma

Advanced Hepatocellular Carcinoma

China
The First Affiliated Hospital with Nanjing Medical...
Jiangsu Hengrui Pharmaceuticals Co.,Ltd

Not yet recruiting

To Evaluate the Efficacy of Adebrelimab Combined With Chemotherapy After HIFU Induction Neoadjuvant Therapy HR+/HER2- Breast Cancer

Breast Cancer | HR+/HER2- Breast Cancer
Merck Sharp & Dohme LLC

Not yet recruiting

Substudy 06C: A Study of Sacituzumab Tirumotecan (MK-2870) With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)

Esophageal Cancer | Esophageal Neoplasms | Gastroesophageal Adenocarcinoma | Gastroesophageal Junction
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Virus-associated Tumour Microenvironment (VIRONMENT)

Lymphoma | Cancers of the Lung | Cancer Anal Canal
Centre Hospitalier Régional d'Orléans

Not yet recruiting

Impact of Hospital Pharmacist on Drug Management in Patients With Bronchopulmonary Cancer (IMPACTO)

Patients With Bronchopulmonary Cancer
Chinese University of Hong Kong

Recruiting

Boiled Tree Nut for Oral Immunotherapy in Food-allergic Children

Food Allergy | Food Allergy in Children

Hong Kong
Mikko Niemi
University of Helsinki

Recruiting

KF2023#1-Trial: Influence of Statin Intake on Cellular Readouts

Pharmacodynamics

Finland
Xin-Hua Xu

Recruiting

A Prospective, Open-label, Single-center, Single-arm Phase II Clinical Study of Cadonilimab (AK104) Combined With Monotherapy Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer With Negative Driver Genes and Failed Immunotherapy

Non-small Cell Lung Cancer

China
Regeneron Pharmaceuticals

Not yet recruiting

A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers

Fallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal Carcinoma

United States
M.D. Anderson Cancer Center

Not yet recruiting

Prebiotic Food-enriched Diet (PreFED) to Enhance the Microbiome and Response to First-line Immunotherapy in Unresectable Melanoma

Unresectable Melanoma

United States

3

Subscribe